Načítá se...
Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects?
An 80‐year‐old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever, and critically low O(2) saturation and definitive chest computerized tomography scan findings in favor of COVID‐19 and positive PCR results in 48 hours. He received antiviral trea...
Uloženo v:
| Vydáno v: | J Med Virol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7262240/ https://ncbi.nlm.nih.gov/pubmed/32270515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.25839 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|